{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:37:53Z","timestamp":1764103073584},"reference-count":17,"publisher":"Geotar-Media Publishing Group","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiol Sosud Khir"],"published-print":{"date-parts":[[2019]]},"DOI":"10.33529\/angio2019405","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T16:33:22Z","timestamp":1576773202000},"page":"102","source":"Crossref","is-referenced-by-count":9,"title":["Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia"],"prefix":"10.33029","volume":"25","author":[{"given":"V. Iu.","family":"Bogachev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. V.","family":"Boldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Iu.","family":"Turkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. N.","family":"Lobanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18453","reference":[{"key":"key-10.33529\/ANGIO2019405-1","unstructured":"Savel'ev VS, Kirienko AI, Bogachev VYu. Khronicheskie zabolevaniya ven v Rossiiskoi Federatsii. Rezul'taty mezhdunarodnoi issledovatel'skoi programmy VEIN CONSULT. Flebologiya. 2010; 4: 3: 9-12."},{"key":"key-10.33529\/ANGIO2019405-2","unstructured":"Rabe E, Guex J-J, Puskas A, et al. The VCP Coordinators Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int. Angiol. 2012; 31: 2: 105-115."},{"key":"key-10.33529\/ANGIO2019405-3","doi-asserted-by":"crossref","unstructured":"Rabe E, Breu F, Cavezzi A, et al. Guideline Group. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014; 29: 6: 338-354.","DOI":"10.1177\/0268355513483280"},{"key":"key-10.33529\/ANGIO2019405-4","unstructured":"Management of Chronic Venous disease. Clinical Practice Guidelines of the European Society for Vascular Surgery. Eur. J. Vasc. Endovasc. Surg. 2015; 49: 6: 678-737."},{"key":"key-10.33529\/ANGIO2019405-5","unstructured":"Rossiiskie klinicheskie rekomendatsii po diagnostike i lecheniyu khronicheskikh zabolevanii ven. Flebologiya. 2018; 12: 3: 146-240."},{"key":"key-10.33529\/ANGIO2019405-6","doi-asserted-by":"crossref","unstructured":"De Souza MD, Cyrino FZ, Mayall MR, et al. Beneficial effects of the micronized purified flavonoid fraction (MPFF, Daflon\u00ae 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology. 2016; 31: 1: 505-506.","DOI":"10.1177\/0268355514564414"},{"key":"key-10.33529\/ANGIO2019405-7","unstructured":"Pitsch F. Benefit of Daflon 500 mg in combination with sclerotherapy of telangiectasias of the lower limbs: results from the SYNERGY and SATISFY surveys. Phlebolymphology. 2011; 19: 182-187."},{"key":"key-10.33529\/ANGIO2019405-8","unstructured":"Reina L. How to manage complications after sclerotherapy. Phlebolymphology.2017; 24: 3:130-143."},{"key":"key-10.33529\/ANGIO2019405-9","doi-asserted-by":"crossref","unstructured":"Bogachev V, Boldin B, Lobanov V. Benefits of Micronized Purified Flavonoid Fraction as adjuvant therapy on the inflammatory response after sclerotherapy. Int. Angiol. 2018; 37: 1: 71-78.","DOI":"10.23736\/S0392-9590.17.03868-8"},{"key":"key-10.33529\/ANGIO2019405-10","doi-asserted-by":"crossref","unstructured":"Bogachev V, Boldin B, Turkin P. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1 Adv. Ther. 2018 Jul; 35: 7: 1001-1008.","DOI":"10.1007\/s12325-018-0731-z"},{"key":"key-10.33529\/ANGIO2019405-11","doi-asserted-by":"crossref","unstructured":"Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A, eds. Duplex Ultrasound Investigation of the Veins in Chronic Venous Disease of the Lower Limbs UIP Consensus Document. Part I. Basic Principles. UIP Manual. Rabe Medical Publishing Bonn; 2008: 88-104.","DOI":"10.1024\/0301-1526.36.1.53"},{"key":"key-10.33529\/ANGIO2019405-12","unstructured":"Bogachev VYu. Mestnoe lechenie khronicheskikh zabolevanii ven. Farmateka (poliklinika). 2013; 10: 53-57."},{"key":"key-10.33529\/ANGIO2019405-13","unstructured":"Bogachev VYu. Mestnye lekarstvennye formy vo flebologicheskoi praktike. Spravochnik poliklinicheskogo vracha. 2010; 8: 63-66."},{"key":"key-10.33529\/ANGIO2019405-14","doi-asserted-by":"crossref","unstructured":"Savel'eva MI, Sychev DA. Vozmozhnosti transdermal'nykh sistem dostavki lekarstvennykh sredstv, primenyaemykh pri khronicheskikh zabolevaniyakh ven. Flebologiya. 2018; 12: 1: 40-49.","DOI":"10.17116\/flebo201812140-49"},{"key":"key-10.33529\/ANGIO2019405-15","doi-asserted-by":"crossref","unstructured":"Dudek-Makuch M, Studzinska-Sroka E. Horse chestnut- efficacy and safety in chronic venous insufficiency: an overview. Revista Brasileira de Farmacognosia. 2015; 25: 533-541.","DOI":"10.1016\/j.bjp.2015.05.009"},{"key":"key-10.33529\/ANGIO2019405-16","doi-asserted-by":"crossref","unstructured":"Bogachev VYu, Boldin BV, Dzhenina OV. Eskuzan: farmakologiya, farmakokinetika i terapevticheskie kharakteristiki. Statsionarozameshchayushchie tekhnologii: Ambulatornaya khirurgiya. 2019; 1-2: 73-74: 19-25.","DOI":"10.21518\/1995-1477-2019-1-2-19-25"},{"key":"key-10.33529\/ANGIO2019405-17","unstructured":"Bogachev VYu, Boldin BV, Turkin PYu. Sovremennaya terapiya khronicheskikh zabolevanii ven nizhnikh konechnostei: v fokuse - transdermal'nye flebotropnye preparaty. RMZh. 2018; 6(II): 61-65."}],"container-title":["Angiology and vascular surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T23:52:33Z","timestamp":1665273153000},"score":1,"resource":{"primary":{"URL":"https:\/\/elibrary.ru\/item.asp?id=41308104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["ANGIO2019405"],"URL":"https:\/\/doi.org\/10.33529\/angio2019405","relation":{},"ISSN":["1027-6661"],"issn-type":[{"value":"1027-6661","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}